Abstract
A nickel-catalyzed deaminative cyanation of Katritzky pyridinium salts has been developed. When coupled with formation of the pyridinium salt from primary amines, this method enables alkyl amines to be converted to alkyl nitriles. A less toxic cyanide reagent, Zn(CN)2, is utilized, and diverse functional groups and heterocycles are tolerated. The method also enables a one-carbon homologation of alkyl amines via reduction of the nitrile products, in addition to many other potential transformations of the versatile nitrile group.
Graphical Abstract
An alkyl nitrile is one of the most common groups in bioactive molecules, ranking as the 15th most common functional group and found in 5.2% of bioactive molecules (Scheme 1A).1 This prevalence is due to nitriles’ effective bonding in protein active sites.2 A nitrile is also a versatile precursor for a wide variety of functional groups.3 Because of this utility, elegant methods have been developed for nitrile incorporation. These methods typically employ alkyl halides as substrates and install the nitrile via either an SN2 or transition metal-catalyzed reaction with a cyanide source (Scheme 1B).4 Because of the sensitivity of alkyl halides to substitution or elimination under many reaction conditions, their use mandates strategic timing of this cyanation sequence, often at the beginning of the synthesis.
Scheme 1. Alkyl nitriles and cyanation reactions.
aPrices of bulk quantities (≥1 kg) from MilliporeSigma on 5/23/2021
In contrast to an alkyl halide, an alkyl amine offers tremendous flexibility in synthetic strategy; an amine can be functionalized early or, via suitable protection, carried through multiple synthetic steps and revealed for a late-stage transformation.5 In addition, amines are ubiquitous and diverse, spanning simple starting materials of exceptional availability and variety to complex pharmaceutical intermediates and APIs.5–6 We envisioned that a deaminative cyanation would be possible via a Katritzky pyridinium salt.7 Starting from an alkyl amine 1, condensation with the commercially available pyrylium salt 2 gives pyridinium 3,8 which would deliver alkyl nitrile 4 via a nickel-catalyzed cyanation (Scheme 1C). Use of a relatively low toxicity cyanide source, typically enabled by a transition metal-catalyzed approach,9 would further increase the utility of this method. Not only would this strategy enable complex, drug-like alkyl amines to be converted into alkyl nitriles with potential bioactivity against new targets, it would also offer the opportunity for a one-carbon homologation of alkyl amines. As shown by the comparison of β-alanine and γ-aminobutyric acid, the addition of a single methylene can have dramatic impact on the bioactivity and cost (Scheme 1D).10 However, a one-carbon homologation of a lead compound would typically require complete re-synthesis. Using a cyanation/reduction sequence enables the original amine to be directly converted to the homologated product. Notably, this new amine product could then be used in the suite of deaminative reactions that have been developed since 2017.7, 11
We selected the cyanation of pyridinium 3a for reaction development. Inspired by the work of Liu and co-workers using Zn(CN)2 as a less toxic cyanide source in reactions with alkyl halides, we selected Zn(CN)2 as our coupling partner.4d Using the bidentate bipy ligand, which is commonly employed in nickel-catalyzed reactions of pyridinium salts, poor reactivity was observed (Table 1, entry 1). In contrast, the use of Xantphos provided 72% yield (entry 2). Notably, Liu also used Xantphos in their cyanation.4d Yield was further improved by the addition of zinc halide salts, with 87% yield observed when ZnBr2 was used (entries 3 and 4). Because the Ni/Xantphos catalyst system is unprecedented in deaminative couplings of pyridinium salts and unusual in NiI/III catalysis, we investigated the use of related ligands. Although P-alkyl Xantphos derivatives completely failed (entry 5), related P-aryl ligands with large bite angles could be used (entries 6 and 7). These results are consistent with Diao’s observation that the large bite angle of Xantphos can stabilize the necessary Ni(I) intermediate, and that bulky P-alkyl groups prevent productive cross-coupling.12 In addition, control experiments demonstrated that both nickel and ligand are required (entries 8 and 9); competitive SN2 displacement does not occur at this reaction temperature for either primary or secondary alkylpyridinium salts (see 6 in Scheme 2 for primary example).
Table 1.
Optimizationa
![]() | ||||
---|---|---|---|---|
entry | [Ni] | ligand | additive | yield (%)b |
1 | NiCl2 | bipy | none | <5 |
2 | NiCl2 | Xantphos | none | 72 |
3 | NiCl2 | Xantphos | ZnCl2 | 80 |
4 | NiCl2 | Xantphos | ZnBr2 | 87 |
5 | NiCl2 | t-Bu-Xantphos | ZnBr2 | <5 |
6 | NiCl2 | DPE-Phos | ZnBr2 | 52 |
7 | NiCl2 | dppf | ZnBr2 | 47 |
8 | NiCl2 | none | ZnBr2 | <5 |
9 | none | Xantphos | ZnBr2 | <5 |
Conditions: 3a (0.10 mmol), Zn(CN)2 (1.0 equiv), [Ni] (10 mol %), ligand (12 mol %), Et2Zn (0.4 equiv), additive (1.0 equiv), DMSO (0.2 M), 80 °C, 16 h, unless otherwise noted.
Determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as internal standard.
Scheme 2. Scopea.
a Conditions: 3 (1.0 mmol), Zn(CN)2 (1.0 equiv), NiCl2 (10 mol %), Xantphos (12 mol %), Et2Zn (0.40 equiv), ZnBr2 (1.0 equiv), DMSO (0.2 M), 80 °C, 16 h, unless otherwise noted. b 0.1 mmol scale. Yield determined by 1H NMR analysis using 1,3,5-trimethoxybenzene as internal standard. c Without ZnBr2. d 2.1:1 dr. e 24 h.
Under these optimized conditions (see Table 1, entry 4), we observed broad scope across an array of Katritzky pyridinium salts. Both primary and secondary alkylpyridinium salts were compatible (Scheme 2). Various functional groups are well tolerated, including acetal (6), benzonitrile (7), carbamate (9, 11, 13), tertiary amine (10, 13), and ester (15, 16) groups. Excellent heterocycle incorporation is exemplified by pyridine 8, azetidine 9, pyrrolidine 10, piperidines 11 and 12, pyrimidine 12, and piperazine 13. Notably, a reactive benzylic pyridinium salt could also be utilized in this cyanation with good yield (14). Additionally, pyridinium salts with β-electron withdrawing groups often suffer elimination under basic reaction conditions.7a However, these types of pyridinium salts worked well in this cyanation, as shown by nitrile 16.
Generality of this methodology was demonstrated by late-stage functionalization of natural products, pharmaceuticals, and pharmaceutical intermediates (Scheme 2). The cyanation of terpene-derived amines, (−)-cis-myrtanylamine (17) and pinanamine (18) proceeded in acceptable yields. The pyridinium salts of amine intermediates in the syntheses of the antidepressant drug agomelatine,13 Lipitor®,14 and mosapride15 were efficiently converted to nitriles 19, 20, and 21 in excellent yields. Ester derivatives of the muscle spasticity treatment, baclofen (22),16 and bleeding disorder treatment, tranexamic acid (23),17 were also effective as pyridinium substrates. Finally, the cyanation of the pyridinium salt of the diterpene amine, leelamine (24),18 proceeded in moderate yield. Additional functional group robustness was also noticed in these examples, including ketal 20, morpholine 21, and aryl chloride 22.
We have also demonstrated the use of this cyanation in an efficient one-carbon homologation of amine 25 to Boc-protected amine 26 (Scheme 3). We first tried a one-pot procedure, in which we simply added the reagents for each step sequentially to the same reaction vessel. However, pyridinium formation is incompatible with the use of DMSO as solvent, and the cyanation was sensitive to EtOH, which would typically be used for pyridinium formation. In addition, the presence of DMSO in the nitrile reduction diminishes yield by competitive reduction. We found that much higher yields and cleaner reactions were achieved if a simple filtration and concentration procedure followed pyridinium formation and cyanation. Under these conditions, 44% overall yield was achieved in the one-carbon homologation of 25 to 26, which compares favorably to the 53% overall yield observed with careful purification after each step. This protocol gives medicinal chemists another useful tool to homologate alkyl primary amines efficiently.
Scheme 3.
One-carbon homologation
With respect to the reaction mechanism, key steps likely include formation of a (Xantphos)Ni(CN) species, single-electron transfer (SET) from a Ni(0) or Ni(I) intermediate to the alkylpyridinium salt to generate an alkyl radical, and either inner or outer sphere attack of that radical on a nickel cyanide intermediate to ultimately deliver product. The role of Et2Zn appears to be predominantly as a reductant (see Supporting Information), and the formation of both diastereomers of 15 are consistent with an alkyl radical intermediate. Further studies are ongoing to establish why Xantphos is particularly effective, as well as the role of the ZnBr2 additive.
In summary, we have developed a nickel-catalyzed cyanation via deamination of Katritzky pyridinium salts. A broad scope of primary and secondary alkyl amine precursors, easy preparation of pyridinium salts, and practical cyanation conditions with a less toxic cyanide source makes this method a powerful tool to discover new molecules, particularly nitriles and nitrile derivatives, including homologated amines.
Supplementary Material
ACKNOWLEDGMENT
We thank NIH (R35 GM131816). J.C.T. thanks the Chemistry-Biology Interface program (NIH T32-GM133395). Data were acquired at UD on instruments obtained with assistance of NSF and NIH funding (NSF CHE0421224, CHE1229234, CHE0840401, and CHE1048367; NIH P20 GM104316, P20 GM103541, and S10 OD016267).
Footnotes
Supporting Information Available:
Additional optimization and mechanistic experiments, detailed experimental procedures, and full spectroscopic data for new compounds (PDF)
REFERENCES
- 1.Ertl P; Altmann E; McKenna JM, The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time. J. Med. Chem 2020, 63 (15), 8408–8418. 10.1021/acs.jmedchem.0c00754. [DOI] [PubMed] [Google Scholar]
- 2.Fleming FF; Yao L; Ravikumar PC; Funk L; Shook BC, Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore. J. Med. Chem 2010, 53 (22), 7902–7917. 10.1021/jm100762r. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Yan G; Zhang Y; Wang J, Recent Advances in the Synthesis of Aryl Nitrile Compounds. Adv. Synth. Catal 2017, 359 (23), 4068–4105. 10.1002/adsc.201700875. [DOI] [Google Scholar]
- 4.(a) Smiley R; Arnold C, Notes- Aliphatic Nitriles from Alkyl Chlorides. J. Org. Chem 1960, 25 (2), 257–258. 10.1021/jo01072a600; [DOI] [Google Scholar]; (b) Wang Z, Kolbe Nitrile Synthesis. In Comprehensive Organic Name Reactions and Reagents, Wang Z, Ed. John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2010. 10.1002/9780470638859.conrr370; [DOI] [Google Scholar]; (c) Ratani TS; Bachman S; Fu GC; Peters JC, Photoinduced, Copper-Catalyzed Carbon–Carbon Bond Formation with Alkyl Electrophiles: Cyanation of Unactivated Secondary Alkyl Chlorides at Room Temperature. J. Am. Chem. Soc 2015, 137 (43), 13902–13907. 10.1021/jacs.5b08452; [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Xia A; Xie X; Chen H; Zhao J; Zhang C; Liu Y, Nickel-Catalyzed Cyanation of Unactivated Alkyl Chlorides or Bromides with Zn(CN)2. Org. Lett 2018, 20 (23), 7735–7739. 10.1021/acs.orglett.8b03539. [DOI] [PubMed] [Google Scholar]
- 5.(a) Lawrence SA, Amines: Synthesis, Properties and Applications Cambridge University Press: New York, NY, 2004; [Google Scholar]; (b) Nugent TC, Chiral Amine Synthesis Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, 2010. [Google Scholar]
- 6.(a) McGrath NA; Brichacek M; Njardarson JT, A Graphical Journey of Innovative Organic Architectures That Have Improved Our Lives. J. Chem. Educ 2010, 87 (12), 1348–1349. 10.1021/ed1003806; [DOI] [Google Scholar]; (b) Ruiz-Castillo P; Buchwald SL, Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions. Chem. Rev 2016, 116 (19), 12564–12649. 10.1021/acs.chemrev.6b00512; [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Liu Y; Ge H, Site-selective C–H arylation of primary aliphatic amines enabled by a catalytic transient directing group. Nat. Chem 2017, 9 (1), 26–32. 10.1038/nchem.2606. [DOI] [Google Scholar]
- 7.(a) Basch CH; Liao J; Xu J; Piane JJ; Watson MP, Harnessing Alkyl Amines as Electrophiles for Nickel-Catalyzed Cross Couplings via C–N Bond Activation. J. Am. Chem. Soc 2017, 139 (15), 5313–5316. 10.1021/jacs.7b02389; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) He F-S; Ye S; Wu J, Recent Advances in Pyridinium Salts as Radical Reservoirs in Organic Synthesis. ACS Catal 2019, 9 (10), 8943–8960. 10.1021/acscatal.9b03084; [DOI] [Google Scholar]; (c) Li Y-N; Xiao F; Guo Y; Zeng Y-F, Recent Developments in Deaminative Functionalization of Alkyl Amines. Eur. J. Org. Chem 2020, 2021, 1215–1228. 10.1002/ejoc.202001193. [DOI] [Google Scholar]
- 8.Katrizky AR; Marson CM, Pyrylium Mediated Transformations of Primary Amino Groups into Other Functional Groups. Angew. Chem., Int. Ed 1984, 23, 420–429. 10.1002/anie.198404201. [DOI] [Google Scholar]
- 9.Anbarasan P; Schareina T; Beller M, Recent developments and perspectives in palladium-catalyzed cyanation of aryl halides: synthesis of benzonitriles. Chem. Soc. Rev 2011, 40 (10), 5049–5067. 10.1039/C1CS15004A. [DOI] [PubMed] [Google Scholar]
- 10.(a) Boonstra E; de Kleijn R; Colzato LS; Alkemade A; Forstmann BU; Nieuwenhuis S, Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Front. Psychol 2015, 6 (1520). 10.3389/fpsyg.2015.01520; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Chen C; Hu J; Yang C; Zhang Y; Wang F; Mu Q; Pan F; Xu H; Lu JR, Amino acid side chains affect the bioactivity of designed short peptide amphiphiles. J. Mater. Chem. B 2016, 4 (13), 2359–2368. 10.1039/C6TB00155F. [DOI] [PubMed] [Google Scholar]
- 11.(a) Plunkett S; Basch CH; Santana SO; Watson MP, Harnessing Alkylpyridinium Salts as Electrophiles in Deaminative Alkyl–Alkyl Cross-Couplings. J. Am. Chem. Soc 2019, 141 (6), 2257–2262. 10.1021/jacs.9b00111; [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Liao J; Basch CH; Hoerrner ME; Talley MR; Boscoe BP; Tucker JW; Garnsey MR; Watson MP, Deaminative Reductive Cross-Electrophile Couplings of Alkylpyridinium Salts and Aryl Bromides. Org. Lett 2019, 21 (8), 2941–2946. 10.1021/acs.orglett.9b01014; [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Liao J; Guan W; Boscoe BP; Tucker JW; Tomlin JW; Garnsey MR; Watson MP, Transforming Benzylic Amines into Diarylmethanes: Cross-Couplings of Benzylic Pyridinium Salts via C–N Bond Activation. Org. Lett 2018, 20 (10), 3030–3033. 10.1021/acs.orglett.8b01062; [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Wu J; Grant PS; Li X; Noble A; Aggarwal VK, Catalyst-Free Deaminative Functionalizations of Primary Amines by Photoinduced Single-Electron Transfer. Angew. Chem., Int. Ed 2019, 58 (17), 5697–5701. 10.1002/anie.201814452; [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Wu J; He L; Noble A; Aggarwal VK, Photoinduced Deaminative Borylation of Alkylamines. J. Am. Chem. Soc 2018, 140 (34), 10700–10704. 10.1021/jacs.8b07103; [DOI] [PubMed] [Google Scholar]; (f) Klauck FJR; James MJ; Glorius F, Deaminative Strategy for the Visible-Light-Mediated Generation of Alkyl Radicals. Angew. Chem., Int. Ed 2017, 56 (40), 12336–12339. 10.1002/anie.201706896; [DOI] [PubMed] [Google Scholar]; (g) Klauck FJR; Yoon H; James MJ; Lautens M; Glorius F, Visible-Light-Mediated Deaminative Three-Component Dicarbofunctionalization of Styrenes with Benzylic Radicals. ACS Catal 2019, 9 (1), 236–241. 10.1021/acscatal.8b04191; [DOI] [Google Scholar]; (h) Martin-Montero R; Yatham VR; Yin H; Davies J; Martin R, Ni-catalyzed Reductive Deaminative Arylation at sp(3) Carbon Centers. Org. Lett 2019, 21 (8), 2947–2951. 10.1021/acs.orglett.9b01016; [DOI] [PubMed] [Google Scholar]; (i) Sun SZ; Romano C; Martin R, Site-Selective Catalytic Deaminative Alkylation of Unactivated Olefins. J. Am. Chem. Soc 2019, 141 (41), 16197–16201. 10.1021/jacs.9b07489. [DOI] [PubMed] [Google Scholar]
- 12.Diccianni JB; Katigbak J; Hu C; Diao T, Mechanistic Characterization of (Xantphos)Ni(I)-Mediated Alkyl Bromide Activation: Oxidative Addition, Electron Transfer, or Halogen-Atom Abstraction. J. Am. Chem. Soc 2019, 141 (4), 1788–1796. 10.1021/jacs.8b13499. [DOI] [PubMed] [Google Scholar]
- 13.Millan MJ; Gobert A; Lejeune F; Dekeyne A; Newman-Tancredi A; Pasteau V; Rivet JM; Cussac D, The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways. J. Pharmacol. Exp. Ther 2003, 306 (3), 954. 10.1124/jpet.103.051797. [DOI] [PubMed] [Google Scholar]
- 14.Roth BD, 1 The Discovery and Development of Atorvastatin, A Potent Novel Hypolipidemic Agent. In Progress in Medicinal Chemistry, King FD; Oxford AW; Reitz AB; Dax SL, Eds. Elsevier: 2002; Vol. 40, pp 1–22. 10.1016/S0079-6468(08)70080-8. [DOI] [PubMed] [Google Scholar]
- 15.Kato S; Morie T; Yoshida N, Synthesis and Biological Activities of Metabolites of Mosapride, a New Gastroprokinetic Agent. Chem. Pharm. Bull 1995, 43 (4), 699–702. 10.1248/cpb.43.699. [DOI] [PubMed] [Google Scholar]
- 16.Froestl W, Chemistry and Pharmacology of GABAB Receptor Ligands. In Advances in Pharmacology, Blackburn TP, Ed. Academic Press: 2010; Vol. 58, pp 19–62. 10.1016/S1054-3589(10)58002-5. [DOI] [PubMed] [Google Scholar]
- 17.Bringing women to the forefront of science and medicine. The Lancet 2012, 379 (9819), 867. 10.1016/S0140-6736(12)60286-4. [DOI] [PubMed] [Google Scholar]
- 18.Kuzu OF; Gowda R; Sharma A; Robertson GP, Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport. Mol. Cancer Ther 2014, 13 (7), 1690. 10.1158/1535-7163.MCT-13-0868. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.